Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 9, 2007, Pages 4351-4359

  Akula, James D ^a   Hansen, Ronald M ^a   Martinez Perez, M Elena ^b   Fulton, Anne B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Ciudad Universitaria   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DIGITAL IMAGING; ELECTRORETINOGRAPHY; NONHUMAN; PERINATAL PERIOD; PHOTORECEPTOR; PRIORITY JOURNAL; RAT; RETINA; RETINA BLOOD VESSEL; RETINA ROD; RETROLENTAL FIBROPLASIA; SENSITIVITY AND SENSIBILITY; ANIMAL; DISEASE MODEL; HUMAN; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

OXYGEN;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; HUMANS; INFANT, NEWBORN; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; RODS (RETINA);

EID: 35148835128     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0204     Document Type: Article

References (63)

1. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121:1684-1694.
2. Fulton AB, Hansen RM. Electroretinogram responses and refractive errors in patients with a history of retinopathy prematurity. Doc Ophthalmol. 1995;91:87-100.
3. Reisner DS, Hansen RM, Final O, Petersen RA, Fulton AB. Dark-adapted thresholds in children with histories of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1997;38:1175-1183.
4. Hansen RM, Fulton AB. Background adaptation in children with a history of mild retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2000;41:320-324.
5. Fulton AB, Hansen RM, Petersen RA, Vanderveen DK. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol. 2001;119:499-505.
6. Fulton AB, Hansen RM, Moskowitz A, Barnaby AM. Multifocal ERG in subjects with a history of retinopathy of prematurity. Doc Ophthalmol. 2005;111:7-13.
7. Wellard J, Lee D, Valter K, Stone J. Photoreceptors in the rat retina are specifically vulnerable to both hypoxia and hyperoxia. Vis Neurosci. 2005;22:501-517.
8. Reynaud X, Hansen RM, Fulton AB. Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci. 1995;36:2071-2079.
9. Liu K, Akula JD, Falk C, Hansen RM, Fulton AB. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006;47:2639-2647.
10. Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, Fulton AB. Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci. 2006;47:5447-5452.
11. Provis JM, Leech J, Diaz CM, Penfold PL, Stone J, Keshet E. Development of the human retinal vasculature: cellular relations and VEGF expression. Exp Eye Res. 1997;65:555-568.
12. Reynaud X, Dorey CK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci. 1994;35:3169-3177.
13. Penn JS, Tolman BL, Henry MM. Oxygen-induced retinopathy in the rat: relationship of retinal nonperfusion to subsequent neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3429-3435.
14. Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34:576-585.
15. Penn JS, Henry MM, Tolman BL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res. 1994;36:724-731.
16. 2 variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci. 1995;36:2063-2070.
17. Cunningham S, McColm JR, Wade J, Sedowofia K, McIntosh N, Fleck B. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest Ophthalmol Vis Sci. 2000;41:4275-4280.
18. Fulton AB, Reynaud X, Hansen RM, Lemere CA, Parker C, Williams TP. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci. 1999;40:168-174.
19. Dembinska O, Rojas LM, Varma DR, Chemtob S, Lachapelle P. Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. Invest Ophthalmol Vis Sci. 2001;42:1111-1118.
20. Dembinska O, Rojas LM, Chemtob S, Lachapelle P. Evidence for a brief period of enhanced oxygen susceptibility in the rat model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002;43:2481-2490.
21. Bonting SL, Caravaggio LL, Gouras P. The rhodopsin cycle in the developing vertebrate retina. I. Relation of rhodopsin content, electroretinogram and rod structure in the rat. Exp Eye Res. 1961;1:14-24.
22. Fulton AB, Hansen RM, Findl O. The development of the rod photoresponse from dark-adapted rats. Invest Ophthalmol Vis Sci. 1995;36:1038-1045.
23. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101-111.
24. Findl O, Hansen RM, Fulton AB. The effects of acetazolamide on the electroretinographic responses in rats. Invest Ophthalmol Vis Sci. 1995;36:1019-1026.
25. Hood DC, Birch DG. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci. 1994;35:2948-2961.
26. Lamb TD, Pugh EN Jr. A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol. 1992;449:719-758.
27. Pugh EN Jr, Lamb TD. Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta. 1993;1141:111-149.
28. Penn RD, Hagins WA. Kinetics of the photocurrent of retinal rods. Biophys J. 1972;12:1073-1094.
29. Pugh EN Jr, Falsini B, Lyubarsky AL. The origins of the major rod-and cone- driven components of the rodent electroretinogram and the effect of age and light-rearing history of the magnitude of these components, In: Williams TP, Thistle AB, editors. Photostasis and Related Phenomena. New York: Plenum Press; 1998:93-128.
30. Peachey NS, Alexander KR, Fishman GA. The luminance-response function of the dark-adapted human electroretinogram. Vision Res. 1989;29:263-270.
31. Robson JG, Frishman LJ. Response linearity and kinetics of the cat retina: the bipolar cell component of the dark-adapted electroretinogram. Vis Neurosci. 1995;12:837-850.
32. Wurziger K, Lichtenberger T, Hanitzsch R. On-bipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vision Res. 2001;41:1091-1101.
33. Aleman TS, LaVail MM, Montemayor R, et al. Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vision Res. 2001;41:2779-2797.
34. Martinez-Perez ME, Hughes AD, Stanton AV, et al. Retinal vascular tree morphology: a semi-automatic quantification. IEEE Trans Biomed Eng. 2002;49:912-917.
35. Gelman R, Martinez-Perez ME, Vanderveen DK, Moskowitz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005;46:4734-4738.
36. Martinez-Perez ME, Hughes AD, Thom SA, Bharath AA, Parker KH. Segmentation of blood vessels from red-free and fluorescein retinal images. Med Image Anal. 2007;11:47-61.
37. Szel A, Rohlich P, Caffe AR, Juliusson B, Aguirre G, Van Veen T. Unique topographic separation of two spectral classes of cones in the mouse retina. J Comp Neurol. 1992;325:327-342.
38. Akula JD, Lyubarsky AL, Naarendorp F. The sensitivity and spectral identity of the cones driving the b-wave of the rat electroretinogram. Vis Neurosci. 2003;20:109-117.
39. Moskowitz A, Hansen R, Fulton A. Early ametropia and rod photoreceptor function in retinopathy of prematurity. Optom Vis Sci. 2005;82:307-317.
40. Jones BW, Watt CB, Frederick JM, et al. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol. 2003;464:1-16.
41. Robson JG, Frishman LJ. Dissecting the dark-adapted electroretinogram. Doc Ophthalmol. 1998;95:187-215.
42. Cringle SJ, Yu DY. A multi-layer model of retinal oxygen supply and consumption helps explain the muted rise in inner retinal PO(2) during systemic hyperoxia. Comp Biochem Physiol A Mol Integr Physiol. 2002;132:61-66.
43. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15:4738-4747.
44. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1996;37:290-299.
45. Yourey PA, Gohari S, Su JL, Alderson RF. Vascular endothelial cell growth factors promote the in vitro development of rat photoreceptor cells. J Neurosci. 2000;20:6781-6788.
46. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA. 2002;99:11946-11950.
47. Sandercoe TM, Geller SF, Hendrickson AE, Stone J, Provis JM. VEGF expression by ganglion cells in central retina before formation of the foveal depression in monkey retina: evidence of developmental hypoxia. J Comp Neurol. 2003;462:42-54.
48. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003;34:383-394.
49. Bates D, Taylor GI, Minichiello J, et al. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol. 2003;255:77-98.
50. Gariano RF, Hu D, Helms J. Expression of angiogenesis-related genes during retinal development. Gene Expr Patterns. 2006;6:187-192.
51. Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 1996;114:1210-1217.
52. Cringle SJ, Yu DY, Alder VA. Intraretinal oxygen tension in the rat eye. Graefes Arch Clin Exp Ophthalmol. 1991;229:574-577.
53. Susser M. What is a cause and how do we know one? - a grammar for pragmatic epidemiology. Am J Epidemiol. 1991;133:635-648.
54. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust. 1951;2:48-50.
55. Patz A, Hoeck LE, De La Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol. 1952;35:1248-1253.
56. Ashton N, Ward B, Serpell G. Role of oxygen in the genesis of retrolental fibroplasia; a preliminary report. Br J Ophthalmol. 1953;37:513-520.
57. Bedrossian R. Retinopathy of prematurity (retrolental fibroplasia) and its relationship to oxygen. Ama Arch Opthalmol. 1953;50:266-267.
58. Huggert A. The supply of oxygen to prematures and the appearance of retrolental fibroplasia. Acta Paediatr. 1953;42:147-156.
59. Locke JC. Retrolental fibroplasia definitive role of oxygen administration in its etiology. Ama Arch Opthalmol. 1954;51:73-79.
60. Steinberg RH. Monitoring communications between photoreceptors and pigment epithelial cells: effects of "mild" systemic hypoxia. Friedenwald lecture. Invest Ophthalmol Vis Sci. 1987;28:1888-1904.
61. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991;98:1628-1640.
62. Lahdenranta J, Pasqualini R, Schlingemann RO, et al. An antiangiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc Natl Acad Sci USA. 2001;98:10368-10373.
63. Arden GB, Sidman RL, Arap W, Schlingemann RO. Spare the rod and spoil the eye. Br J Ophthalmol. 2005;89:764-769.